Search

Your search keyword '"Hendrikx, Tim"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Hendrikx, Tim" Remove constraint Author: "Hendrikx, Tim"
188 results on '"Hendrikx, Tim"'

Search Results

2. Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis

3. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease

4. Plasma cathepsin D as an early indicator for alcohol-related liver disease

5. Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH

6. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

7. Antimicrobial proteins: intestinal guards to protect against liver disease

9. MicroRNA-26b protects against MASH development and can be efficiently targeted with lipid nanoparticles

10. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans

14. Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2

17. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr-/- mice, thereby accelerating hepatic fibrosis.

18. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in theMdr2 −/−mouse model of sclerosing cholangitis via immunomodulatory effects

22. Plasma Cholesteryl Ester Transfer Protein Is Predominantly Derived From Kupffer Cells

24. Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects.

25. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans

26. Oxidation-Specific Epitopes in Non-Alcoholic Fatty Liver Disease

28. The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial

32. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells

33. Ultrasonic Perfluorohexane-Loaded Monocyte Imaging Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease

34. Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease

35. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

37. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice

40. Additional file 4: Table S1. of Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease

42. Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation

44. Cathepsin D regulates lipid metabolism in murine steatohepatitis

45. Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice

46. Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention

47. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice

48. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanolinduced liver disease in mice.

49. Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease

50. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells

Catalog

Books, media, physical & digital resources